Heteroaryl carboxamides

US9926311B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Martin Hendrix · Tarrytown, US
• Frank-Gerhard Böβ · Grafton, GB
• Christina Erb · Wiesbaden, DE
• Joachim Krüger · Mülheim an der Ruhr, DE
• Christoph Methfessel · Wuppertal, DE
• Rudy Schreiber · Menlo Park, US
• Welf-Burkhard Wiese · Langenfeld, DE
• Joachim Luithle · Wülfrath, DE

Key dates

• Filing date: Aug 24, 2015
• Grant date: Mar 27, 2018
• Expiry date: Aug 24, 2035

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P25/28
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to novel heteroaryl carboxamides, a process for their preparation, and pharmaceutical compositions containing them. These materials are useful for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.